
AEON Biopharma appoints John Bencich as CFO
Lucy Batizovsky | March 17, 2026 | Appointment | | AEON Biopharma
AEON Biopharma, a biopharmaceutical company, has appointed John Bencich as Chief Financial Officer (CFO).
Bringing more than 25 years of leadership experience to the role, Bencich previously served as Chief Executive Officer (CEO) of Achieve Life Sciences where he led the company’s capitalisation.
Earlier in his career, Bencich held CFO positions at OncoGenex Pharmaceuticals, Integrated Diagnostics, Allozyne and Trubion Pharmaceuticals, where he supported multiple financings, strategic transactions and public-company readiness initiatives.
Bencich said: “I see significant opportunity to strengthen the company’s financial foundation and support the next stage of growth to help fully realise its potential.”
AEON is currently preparing to move through a new phase of critical regulatory milestones.
Rob Bancroft, President and Chief Executive Officer of AEON, said: “John’s appointment represents an important step forward for AEON as we enter a period of accelerated execution.
“His deep experience leading finance organisations at publicly traded biotechnology companies, combined with his capital markets expertise, will strengthen our financial strategy, deepen institutional engagement, and support disciplined capital formation as we advance our regulatory pathway.”






